Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DHR | US
-1.32
-0.74%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
177.25
178.57
178.94
176.49
Danaher Corporation designs manufactures and markets professional medical industrial and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies consumables and services; lab filtration separation and purification; lab-scale protein purification and analytical tools; reagents membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry genomics lab automation centrifugation particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical food and beverage medical and life sciences companies as well as universities medical schools and research institutions and various industrial manufacturers. The Diagnostics segment provides chemistry immunoassay microbiology and automation systems as well as hematology molecular acute care and pathology diagnostics products. This segment offers clinical instruments reagents consumables software and services for hospitals physicians' offices reference laboratories and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation consumables software services and disinfection systems to analyze treat and manage ultra-pure potable industrial waste ground source and ocean water in residential commercial municipal industrial and natural resource applications. It also provides instruments software services and consumables for various color and appearance management packaging design and quality management packaging converting printing marking coding and traceability applications for consumer pharmaceutical and industrial products. The company was formerly known as Diversified Mortgage Investors Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington the District of Columbia.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
36.8%1 month
33.6%3 months
29.2%6 months
25.3%50.44
30.96
3.94
0.36
0.23
29.01
8.96
2.69
7.46B
128.01B
128.01B
0.40
20.34
-18.10
-2.90
7.98
2.02
0.88
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
25.39
Range1M
25.39
Range3M
65.79
Rel. volume
1.49
Price X volume
1.14B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc | IDXX | Diagnostics & Research | 565.93 | 46.58B | 0.89% | 45.46 | 67.58% |
| Agilent Technologies Inc | A | Diagnostics & Research | 115.55 | 33.20B | 0.99% | 28.92 | 49.67% |
| IQVIA Holdings Inc | IQV | Diagnostics & Research | 162.28 | 29.58B | 1.00% | 30.78 | 200.33% |
| Mettler-Toledo International Inc | MTD | Diagnostics & Research | 1282.45 | 27.21B | 1.43% | 37.74 | -1347.12% |
| Koninklijke Philips N.V | PHG | Diagnostics & Research | 27.47 | 25.60B | -0.58% | n/a | 69.56% |
| Natera Inc | NTRA | Diagnostics & Research | 203.75 | 25.20B | 1.30% | n/a | 52.31% |
| DexCom Inc | DXCM | Diagnostics & Research | 61.57 | 24.67B | -1.80% | 44.96 | 106.57% |
| Laboratory Corporation of America Holdings | LH | Diagnostics & Research | 263.8 | 22.15B | -0.42% | 40.18 | 74.63% |
| Quest Diagnostics Incorporated | DGX | Diagnostics & Research | 196.27 | 21.85B | -1.63% | 20.22 | 76.89% |
| Illumina Inc | ILMN | Diagnostics & Research | 127.88 | 20.37B | 1.95% | n/a | 203.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Carrier Global Corporation | CARR | Building Products & Equipment | 60.97 | 55.04B | -0.93% | 21.69 | 100.40% |
| Netflix Inc | NFLX | Media - Diversified | 92.44 | 39.67B | -0.41% | 43.23 | 70.34% |
| Live Nation Entertainment Inc | LYV | Media - Diversified | 156.64 | 36.36B | 2.24% | 105.45 | -18562.20% |
| PPL Corporation | PPL | Building Products & Equipment | 38.75 | 28.59B | 0.54% | 28.90 | 114.80% |
| Twenty-First Century Fox Inc | FOXA | Media - Diversified | 62.85 | 27.58B | -2.60% | 13.57 | 76.09% |
| Twenty-First Century Fox Inc | FOX | Media - Diversified | 56.17 | 26.86B | -2.72% | 12.45 | 76.09% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 29.01 | 12.67 | Expensive |
| Ent. to Revenue | 8.96 | 44.00 | Cheaper |
| PE Ratio | 50.44 | 40.09 | Expensive |
| Price to Book | 3.94 | 77.50 | Cheaper |
| Dividend Yield | 0.40 | 1.18 | Poor |
| Std. Deviation (3M) | 29.24 | 59.59 | Lower Risk |
| Debt to Equity | 0.36 | -14.36 | Expensive |
| Debt to Assets | 0.23 | 0.34 | Cheaper |
| Market Cap | 128.01B | 13.71B | Market Leader |